Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01623687
Other study ID # GUllmark Apr -12
Secondary ID
Status Recruiting
Phase Phase 4
First received January 17, 2012
Last updated April 3, 2014
Start date August 2011
Est. completion date March 2015

Study information

Verified date April 2014
Source Uppsala University
Contact Gösta Ullmark, MD, PhD
Phone +46706466149
Email gosta.ullmark@lg.se
Is FDA regulated No
Health authority Sweden: Regional Ethical Review BoardSweden: Swedish National Council on Medical Ethics
Study type Interventional

Clinical Trial Summary

What is the intensity of F-PET uptake in healthy and osteo arthritic femur and acetabulum, compared to the uptake adjacent to four analyzed endoprosthetic components 1½ and 6 months after surgery?


Description:

A clinical study of 26 patients, age 50-69 years, healthy unless osteoarthritis in one hip, randomized in four groups plus a reference group of same 26 patient´s contralateral healthy hip.

Intervention will be surgery with a total hip arthroplasty. The studied endoprosthetic components are: Cemented Lubinus SP II stem with a ceramic 32 mm head, a cemented Lubinus cross linked cup (Waldemar Link, Hamburg, Germany). Palacose cement with gentamycin, applied with 3:rd generation cementation technique will be used for those cemented implants.

Uncemented HA-coated Corail stem with a ceramic 32 mm head (DePuy, Johnson & Johnson, USA), a fibrous metal Regenerex RingLoc cup (Biomet, Warsaw, Il, USA) All cups will have cross linked Ultra-high-molecular-weight polyethylene (UHWMP).

Clinical score, radiography and PET uptake of Fluoride tracer (SUV) adjacent to the prosthetic surfaces will be analyzed.


Recruitment information / eligibility

Status Recruiting
Enrollment 26
Est. completion date March 2015
Est. primary completion date September 2014
Accepts healthy volunteers No
Gender Both
Age group 50 Years to 69 Years
Eligibility Inclusion Criteria:

- patients diagnosed to have unilateral hip osteo arthritis (Charnley group A) aimed for THA at the orthopedic clinic Gävle hospital.

Exclusion Criteria:

- Systemic disease or medication affecting the skeleton

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Component for acetabulum (Regenerex RingLoc cup)
A fibrous metal uncemented Regenerex RingLoc cup (Biomet, Warsaw, Il, USA)
Components for the acetabulum (Lubinus cross linked cup)
cemented Lubinus cross linked cup (Waldemar Link, Hamburg, Germany).
Arthroplasty components are for the femur (Cemented Lubinus SP II stem)
Cemented Lubinus SP II stem (Waldemar Link, Hamburg, Germany) with a ceramic 32 mm head.
Arthroplasty components are for the femur (Corail stem)
Uncemented HA-coated Corail stem with a ceramic 32 mm head (DePuy, Johnsson & Johnsson, USA).

Locations

Country Name City State
Sweden Centre for research and development Uppsala university/County council of Gävleborg Gävle

Sponsors (1)

Lead Sponsor Collaborator
Uppsala University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary FEMUR: to analyze difference in SUV of the 4 upper ROI`s (No 1, 7, 8 and 13) analyzed together between the cemented and uncemented groups AND: to analyze SUV of the 4 upper ROI's analyzed together between each femur study group and the reference group There are two study groups for femur: cemented and uncemented femur prosthetic components. There are also a femur reference group. 6 weeks after surgery No
Primary ACETABULUM: to analyze difference in SUV of all 9 ROI`s analyzed together between the cemented and uncemented acetabular study groups, and to analyze SUV of all 9 ROI`s analyzed together between each acetabulum study group and the reference group There are two study groups for acetabulum: cemented and uncemented acetabular prosthetic components. There are also an acetabular reference group. 6 weeks after surgery No
Secondary FEMUR:to analyze difference in SUV for each individual ROI inbetween the cemented and uncemented femur group 6 weeks and 6 months No
Secondary FEMUR: to analyze difference in SUV for each individual ROI between the cemented study group and the reference group. To analyze difference in SUV for each individual ROI between the uncemented study group and the reference group. 6 weks and 6 months No
Secondary FEMUR:to analyze difference in SUV for each individual ROI between the 3 time points for the cemented group. To analyze difference in SUV for each individual ROI between the 3 time points for the uncemented group. preoperatively, 6 weeks and 6 months No
Secondary FEMUR:to analyze difference in SUV for the 4 upper ROI`s (No 1, 7, 8 and 13)analyzed together between the 2 study groups 6 months No
Secondary FEMUR:to analyze difference in SUV for the 4 upper ROI's analyzed together between each study group and the reference group 6 months No
Secondary ACETABULUM: to analyze difference in SUV for each individual ROI between the 2 study groups 6 weeks and 6 months No
Secondary ACETABULUM: to analyze difference in SUV for each individual ROI between the cemented study group and the reference group. To analyze difference in SUV for each individual ROI between the uncemented study group and the reference group. 6 weeks and 6 months No
Secondary ACETABULUM: to analyze difference in SUV for each individual ROI for the cemented study group between the 3 time points. To analyze difference in SUV for each individual ROI for the uncemented study group between the 3 time points. preoperatively, 6 weeks and 6 months No
Secondary ACETABULUM: to analyze difference in SUV of all 9 ROI`s analyzed together between the cemented and uncemented acetabular study groups 6 months No
Secondary ACETABULUM: to analyze difference in SUV of all 9 ROI`s analyzed together between the cemented and uncemented acetabular study groups, and to analyze SUV of all 9 ROI`s analyzed together between each acetabulum study group and the reference group 6 months No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT01947660 - Continuous Regional Anesthesia for Septic Limb Orthopedic Surgery N/A
Completed NCT03222206 - The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease Phase 4
Active, not recruiting NCT02727764 - A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With Arthritis Phase 1
Completed NCT04515758 - Determining the Feasibility of Implementing a Combined Cognitive and Exercise Training Program for Older Adults in a Community Setting. N/A